Historical source coverage

2026

1719 selected records with a cited source date in 2026, shown 200 per page, newest first. This archive is selective and does not imply continuous monitoring or complete historical coverage.

Explore 2026 by record type

4 types

November 2026

189 records on this page

Literature metadata · Degarelix

Development and Validation of a Stability-Indicating HPLC Method for Degarelix and Characterization of Its Degradation Impurities Using LC-MS, 1H NMR, and FTIR Techniques.

PubMed lists PMID 43041099 in Biomedical chromatography : BMC as Journal Article, with publication-date metadata of 2027-01 (month precision). PeptideScanner associated the retained record with the identity slug degarelix. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Glatiramer acetate

ClinicalTrials.gov record NCT05344469

PeptideScanner retained ClinicalTrials.gov record NCT05344469 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was glatiramer-acetate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT07715903

PeptideScanner retained ClinicalTrials.gov record NCT07715903 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT05278208

PeptideScanner retained ClinicalTrials.gov record NCT05278208 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Survodutide

ClinicalTrials.gov record NCT07940244

PeptideScanner retained ClinicalTrials.gov record NCT07940244 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Petrelintide

ClinicalTrials.gov record NCT07843472

PeptideScanner retained ClinicalTrials.gov record NCT07843472 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was petrelintide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Cagrilintide

ClinicalTrials.gov record NCT07220759

PeptideScanner retained ClinicalTrials.gov record NCT07220759 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was cagrilintide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT04775082

PeptideScanner retained ClinicalTrials.gov record NCT04775082 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06015893

PeptideScanner retained ClinicalTrials.gov record NCT06015893 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05669664

PeptideScanner retained ClinicalTrials.gov record NCT05669664 at 2026-11-16T13:28:59.838Z. Its registry update date was 2026-11-16, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Tirzepatide

Tirzepatide in Adolescents With Obesity: Research Summary.

PubMed lists PMID 43035094 in JAMA as Journal Article, with publication-date metadata of 2026-11-15 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Cerebrolysin

Longitudinal Serum and Cerebrospinal Fluid S100B Concentrations After Aneurysmal Subarachnoid Hemorrhage: An Exploratory Comparison of Historical Cohorts With and Without Cerebrolysin Exposure.

PubMed lists PMID 43030876 in Journal of clinical medicine as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug cerebrolysin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tirzepatide

Early Body-Composition Trajectory During Tirzepatide Treatment for Obesity: A Real-World Bioimpedance Cohort Study.

PubMed lists PMID 43030521 in Journal of clinical medicine as Journal Article, with publication-date metadata of 2026-10-28 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tirzepatide

A Multimodal Intervention Including Tirzepatide in Women with Lipedema and Excess Body Weight: A Pilot Case Series.

PubMed lists PMID 43030785 in Journal of clinical medicine as Journal Article, with publication-date metadata of 2026-11-06 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT04234568

PeptideScanner retained ClinicalTrials.gov record NCT04234568 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Eloralintide

ClinicalTrials.gov record NCT07935304

PeptideScanner retained ClinicalTrials.gov record NCT07935304 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was eloralintide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Carfilzomib

Carfilzomib in combination with R-CHOP for initial treatment of patients with non-germinal center diffuse large B-cell lymphoma: a multicenter, single arm, phase 1/2 study.

PubMed lists PMID 40397818 in Leukemia & lymphoma as Journal Article, Clinical Trial, Phase II, Multicenter Study, Clinical Trial, Phase I, with publication-date metadata of 2025-05-21 (day precision). PeptideScanner associated the retained record with the identity slug carfilzomib. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pegcetacoplan

Pegcetacoplan in C3 Glomerulopathy and Primary Immune-Complex MPGN.

PubMed lists PMID 43024395 in Journal of the American Society of Nephrology : JASN as Journal Article, with publication-date metadata of 2026-11-13 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Leuprolide

ClinicalTrials.gov record NCT05827081

PeptideScanner retained ClinicalTrials.gov record NCT05827081 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was leuprolide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Retatrutide

ClinicalTrials.gov record NCT06297603

PeptideScanner retained ClinicalTrials.gov record NCT06297603 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was retatrutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07935200

PeptideScanner retained ClinicalTrials.gov record NCT07935200 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Regulatory · Exenatide

Federal Register notice 2026-23141

The Federal Register published notice 2026-23141, attributed to FDA and its parent HHS department, on 2026-11-13. Its official title is “Determination That DIBENZYLINE (Phenoxybenzamine Hydrochloride) Oral Capsule, 10 Milligrams, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Exenatide.

Source: Federal Register via GovInfo ↗

→

Literature metadata · Lanreotide

A phase I/II study using cabozantinib and lanreotide as treatments for advanced GEP-NETs for which molecular targeted therapy or chemotherapy have failed (SCALET): TCOG T2221 study.

PubMed lists PMID 42976416 in ESMO open as Journal Article, with publication-date metadata of 2026-11-03 (day precision). PeptideScanner associated the retained record with the identity slug lanreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Octreotide

ClinicalTrials.gov record NCT00569127

PeptideScanner retained ClinicalTrials.gov record NCT00569127 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was octreotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Survodutide

ClinicalTrials.gov record NCT07754461

PeptideScanner retained ClinicalTrials.gov record NCT07754461 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT06772597

PeptideScanner retained ClinicalTrials.gov record NCT06772597 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-13, and PeptideScanner's reviewed identity mapping was setmelanotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT03606577

PeptideScanner retained ClinicalTrials.gov record NCT03606577 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT06152575

PeptideScanner retained ClinicalTrials.gov record NCT06152575 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT04665739

PeptideScanner retained ClinicalTrials.gov record NCT04665739 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT04750954

PeptideScanner retained ClinicalTrials.gov record NCT04750954 at 2026-11-16T02:15:32.969Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT05178693

PeptideScanner retained ClinicalTrials.gov record NCT05178693 at 2026-11-16T02:15:32.969Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT05691465

PeptideScanner retained ClinicalTrials.gov record NCT05691465 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT05773274

PeptideScanner retained ClinicalTrials.gov record NCT05773274 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Pegcetacoplan

ClinicalTrials.gov record NCT06722157

PeptideScanner retained ClinicalTrials.gov record NCT06722157 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was pegcetacoplan.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Kisspeptin-10

Structural basis for Kisspeptin-10 selectivity toward KISS1R: computational insights.

PubMed lists PMID 42707558 in In silico pharmacology as Journal Article, with publication-date metadata of 2026-09-06 (day precision). PeptideScanner associated the retained record with the identity slug kisspeptin-10. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT05433584

PeptideScanner retained ClinicalTrials.gov record NCT05433584 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT05556512

PeptideScanner retained ClinicalTrials.gov record NCT05556512 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07112872

PeptideScanner retained ClinicalTrials.gov record NCT07112872 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07481747

PeptideScanner retained ClinicalTrials.gov record NCT07481747 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07642635

PeptideScanner retained ClinicalTrials.gov record NCT07642635 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Survodutide

ClinicalTrials.gov record NCT07850063

PeptideScanner retained ClinicalTrials.gov record NCT07850063 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07931235

PeptideScanner retained ClinicalTrials.gov record NCT07931235 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07931573

PeptideScanner retained ClinicalTrials.gov record NCT07931573 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07931599

PeptideScanner retained ClinicalTrials.gov record NCT07931599 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Glucagon

US Healthcare Professionals' Management of MASH and Self-Reported Knowledge of GLP-1, GIP, and Glucagon Receptor Agonists.

PubMed lists PMID 42837671 in Clinical and translational gastroenterology as Journal Article, with publication-date metadata of 2026-10-06 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Octreotide

Octreotide-modified pH-responsive nanocomposites for ultrasound imaging-guided chemo-photothermal therapy of prostate cancer.

PubMed lists PMID 42944769 in Nanoscale as Journal Article, with publication-date metadata of 2026-11-12 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

Semaglutide and alcohol use disorder: An evidence gap India must fill.

PubMed lists PMID 43011941 in Indian journal of psychiatry as Letter, with publication-date metadata of 2026-10-21 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Teriparatide

Development of Long-Acting Teriparatide Analogues through Iterative Peptide Scanning and Site-Specific Modification by Serine/Threonine Ligation.

PubMed lists PMID 43018567 in Journal of medicinal chemistry as Journal Article, with publication-date metadata of 2026-11-12 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Setmelanotide

ClinicalTrials.gov record NCT05093634

PeptideScanner retained ClinicalTrials.gov record NCT05093634 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was setmelanotide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06077864

PeptideScanner retained ClinicalTrials.gov record NCT06077864 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07463846

PeptideScanner retained ClinicalTrials.gov record NCT07463846 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06299098

PeptideScanner retained ClinicalTrials.gov record NCT06299098 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Survodutide

ClinicalTrials.gov record NCT06632457

PeptideScanner retained ClinicalTrials.gov record NCT06632457 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was survodutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07734792

PeptideScanner retained ClinicalTrials.gov record NCT07734792 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Vosoritide

ClinicalTrials.gov record NCT06455059

PeptideScanner retained ClinicalTrials.gov record NCT06455059 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was vosoritide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT07481734

PeptideScanner retained ClinicalTrials.gov record NCT07481734 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-12, and PeptideScanner's reviewed identity mapping was tesamorelin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Glucagon

A redox route from cysteine to glucagon secretion.

PubMed lists PMID 43013397 in Cell reports as Journal Article, with publication-date metadata of 2026-11-10 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT07555938

PeptideScanner retained ClinicalTrials.gov record NCT07555938 at 2026-11-17T13:28:01.467Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Pegcetacoplan

ClinicalTrials.gov record NCT03531255

PeptideScanner retained ClinicalTrials.gov record NCT03531255 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was pegcetacoplan.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Pegcetacoplan

Pegcetacoplan for geographic atrophy: Bridging the "clinical relevance gap" through precision medicine.

PubMed lists PMID 42998772 in Survey of ophthalmology as Journal Article, Review, with publication-date metadata of 2026-11-07 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06162715

PeptideScanner retained ClinicalTrials.gov record NCT06162715 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT06778967

PeptideScanner retained ClinicalTrials.gov record NCT06778967 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Retatrutide

ClinicalTrials.gov record NCT07232719

PeptideScanner retained ClinicalTrials.gov record NCT07232719 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was retatrutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07400107

PeptideScanner retained ClinicalTrials.gov record NCT07400107 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT07927972

PeptideScanner retained ClinicalTrials.gov record NCT07927972 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was elamipretide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07929571

PeptideScanner retained ClinicalTrials.gov record NCT07929571 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-11-10, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Tirzepatide

Temporal dynamics and prognostic value of serum calcitonin during tirzepatide therapy in adults with obesity.

PubMed lists PMID 43009382 in Obesity research & clinical practice as Journal Article, with publication-date metadata of 2026-11-10 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Metreleptin

ClinicalTrials.gov record NCT02262806

PeptideScanner retained ClinicalTrials.gov record NCT02262806 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was metreleptin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Metreleptin

ClinicalTrials.gov record NCT05164341

PeptideScanner retained ClinicalTrials.gov record NCT05164341 at 2026-11-16T17:35:38.955Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was metreleptin.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT06955169

PeptideScanner retained ClinicalTrials.gov record NCT06955169 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Pegcetacoplan

ClinicalTrials.gov record NCT07898774

PeptideScanner retained ClinicalTrials.gov record NCT07898774 at 2026-11-16T01:37:14.654Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was pegcetacoplan.

Source: ClinicalTrials.gov ↗

→

Literature metadata · PEG-MGF

Producing human mechano growth factor (MGF) in Escherichia coli.

PubMed lists PMID 18068377 in Protein expression and purification as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-11-07 (day precision). PeptideScanner associated the retained record with the identity slug peg-mgf. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Peginesatide

Peginesatide acetate, axitinib, and pertuzumab.

PubMed lists PMID 23023854 in Journal of the American Pharmacists Association : JAPhA as Journal Article, Review, with publication-date metadata of 2012 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug peginesatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Nafarelin

An attempt to alter the pathophysiology of polycystic ovary syndrome using a gonadotrophin hormone releasing hormone agonist--Nafarelin.

PubMed lists PMID 2533526 in Clinical endocrinology as Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 1989-09 (month precision). PeptideScanner associated the retained record with the identity slug nafarelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dasiglucagon

Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.

PubMed lists PMID 33906916 in Diabetes care as Letter, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-04-27 (day precision). PeptideScanner associated the retained record with the identity slug dasiglucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Dasiglucagon

Dasiglucagon Hydrochloride.

PubMed lists PMID 33998648 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Journal Article, with publication-date metadata of 2021-07-22 (day precision). PeptideScanner associated the retained record with the identity slug dasiglucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Metreleptin

Metreleptin treatment of non-HIV lipodystrophy syndromes.

PubMed lists PMID 34571177 in Presse medicale (Paris, France : 1983) as Journal Article, Review, with publication-date metadata of 2021-09-24 (day precision). PeptideScanner associated the retained record with the identity slug metreleptin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Thymosin beta-4

Role of Thymosin Beta 4 in the diagnosis of Nonalcoholic Fatty Liver and its relation to Metabolic Syndrome in Egyptian patients.

PubMed lists PMID 35436057 in The Egyptian journal of immunology as Journal Article, with publication-date metadata of 2022-04 (month precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Carfilzomib

Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib-cyclophosphamide-dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myel…

PubMed lists PMID 36529145 in The Lancet. Haematology as Clinical Trial, Phase II, Equivalence Trial, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2022-12-15 (day precision). PeptideScanner associated the retained record with the identity slug carfilzomib. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Motixafortide

Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial.

PubMed lists PMID 37069359 in Nature medicine as Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, Journal Article, Research Support, N.I.H., Extramural, and 1 more PubMed publication type, with publication-date metadata of 2023-04-17 (day precision). PeptideScanner associated the retained record with the identity slug motixafortide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Lutetium Lu 177 dotatate

Clinical Pharmacokinetics of Radiopharmaceuticals from SPECT/CT Image Acquisition by Contouring in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Lu-177 DOTATATE (Lutathera®) Case.

PubMed lists PMID 37184824 in European journal of drug metabolism and pharmacokinetics as Journal Article, with publication-date metadata of 2023-05-15 (day precision). PeptideScanner associated the retained record with the identity slug lutetium-lu-177-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Lutetium Lu 177 dotatate

177 Lu-DOTATATE (Lutathera) Therapy in 68 Ga-DOTATATE PET/CT-Negative Liver Metastases of a Neuroendocrine Tumor.

PubMed lists PMID 37883194 in Clinical nuclear medicine as Case Reports, Journal Article, with publication-date metadata of 2023-10-23 (day precision). PeptideScanner associated the retained record with the identity slug lutetium-lu-177-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Humanin

Assessment of mitochondrial peptide humanin in women with polycystic ovary syndrome: serum and skeletal muscle profile.

PubMed lists PMID 41186863 in Journal of endocrinological investigation as Journal Article, with publication-date metadata of 2025-11-04 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Orforglipron

Pharmacokinetic Bioequivalence of Orforglipron Tablets and Capsules in Healthy Participants With Obesity or Overweight.

PubMed lists PMID 41994902 in Diabetes, obesity & metabolism as Clinical Trial, Phase I, Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Motixafortide

Motixafortide, cemiplimab, gemcitabine and nab-paclitaxel in metastatic pancreatic cancer: a single-arm phase 2 study with single-cell correlatives.

PubMed lists PMID 42811017 in Nature communications as Journal Article, Clinical Trial, Phase II, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-08-21 (day precision). PeptideScanner associated the retained record with the identity slug motixafortide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Orforglipron

Orforglipron for Obstructive Sleep Apnea: Research Summary.

PubMed lists PMID 43002163 in JAMA as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug orforglipron. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Efinopegdutide

Efinopegdutide: a step towards precision in MASH therapy?

PubMed lists PMID 43003104 in Lancet (London, England) as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug efinopegdutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Triptorelin

Comparison of dienogest versus triptorelin acetate in premenopausal women with adenomyosis: a prospective clinical trial.

PubMed lists PMID 25990480 in Archives of gynecology and obstetrics as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 2015-05-20 (day precision). PeptideScanner associated the retained record with the identity slug triptorelin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Bivalirudin for Pediatric Procedural Anticoagulation: A Narrative Review.

PubMed lists PMID 29461391 in Anesthesia and analgesia as Journal Article, Review, with publication-date metadata of 2019-01 (month precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Daptomycin

Daptomycin Plus Fosfomycin Versus Daptomycin Alone for Methicillin-resistant Staphylococcus aureus Bacteremia and Endocarditis: A Randomized Clinical Trial.

PubMed lists PMID 32725216 in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Equivalence Trial, with publication-date metadata of 2021-05-04 (day precision). PeptideScanner associated the retained record with the identity slug daptomycin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Bivalirudin versus heparin in adult and pediatric patients with extracorporeal membrane oxygenation therapy: A systematic review and meta-analysis.

PubMed lists PMID 35065202 in Pharmacological research as Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Systematic Review, with publication-date metadata of 2022-01-20 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Bivalirudin vs. heparin in paediatric and adult patients on extracorporeal membrane oxygenation: A meta-analysis.

PubMed lists PMID 35098565 in British journal of clinical pharmacology as Journal Article, Meta-Analysis, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-02-14 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Difelikefalin

New Drugs Update: Finerenone, Difelikefalin, and Avacopan.

PubMed lists PMID 35337427 in The Senior care pharmacist as Journal Article, with publication-date metadata of 2022-04-01 (day precision). PeptideScanner associated the retained record with the identity slug difelikefalin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Bivalirudin versus heparin anticoagulation in patients receiving extracorporeal membrane oxygenation.

PubMed lists PMID 35616224 in Perfusion as Journal Article, Meta-Analysis, with publication-date metadata of 2022-05-26 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Heparin Versus Bivalirudin for Anticoagulation in Adult Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis.

PubMed lists PMID 36355803 in ASAIO journal (American Society for Artificial Internal Organs : 1992) as Meta-Analysis, Systematic Review, Journal Article, with publication-date metadata of 2022-11-09 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Meta-Analysis Comparing Bivalirudin Versus. Unfractionated Heparin in Adult Patients With Extracorporeal Membrane Oxygenation.

PubMed lists PMID 36449392 in Journal of pharmacy practice as Meta-Analysis, Journal Article, with publication-date metadata of 2022-11-30 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Bivalirudin versus heparin in STEMI after BRIGHT-4 trial: an updated meta-analysis.

PubMed lists PMID 37865864 in Coronary artery disease as Meta-Analysis, Journal Article, with publication-date metadata of 2023-09-20 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Terlipressin

A Noninferiority Trial Comparing 2 Days vs 5 Days of Terlipressin and Ceftriaxone in Terms of 5-Day Rebleeding for Patients With Acute Gastroesophageal Variceal Hemorrhage.

PubMed lists PMID 38526204 in The American journal of gastroenterology as Journal Article, Randomized Controlled Trial, Equivalence Trial, Comparative Study, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-05-25 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Bivalirudin in Extracorporeal Membrane Oxygenation.

PubMed lists PMID 39259286 in Journal of cardiovascular pharmacology as Journal Article, Review, with publication-date metadata of 2024-12-01 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Prospective Randomized Pilot Study Comparing Bivalirudin Versus Heparin in Neonatal and Pediatric Extracorporeal Membrane Oxygenation.

PubMed lists PMID 39585174 in Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies as Journal Article, Randomized Controlled Trial, Comparative Study, with publication-date metadata of 2024-11-25 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Retatrutide

ClinicalTrials.gov record NCT05936151

PeptideScanner retained ClinicalTrials.gov record NCT05936151 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was retatrutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07871409

PeptideScanner retained ClinicalTrials.gov record NCT07871409 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Teriparatide

Perioperative teriparatide use in osteopenic and osteoporotic patients undergoing multi- and long-segment posterior spinal fusion.

PubMed lists PMID 42995581 in BMC musculoskeletal disorders as Journal Article, with publication-date metadata of 2026-08-11 (day precision). PeptideScanner associated the retained record with the identity slug teriparatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

Boerhaave Syndrome: Case Report on a Rare Complication of Semaglutide Use.

PubMed lists PMID 42999829 in Cureus as Case Reports, Journal Article, with publication-date metadata of 2026-10-08 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Setmelanotide

Early nutrition impacts later setmelanotide treatment of obesity in mice.

PubMed lists PMID 43001579 in JCI insight as Journal Article, with publication-date metadata of 2026-11-09 (day precision). PeptideScanner associated the retained record with the identity slug setmelanotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vosoritide

A Phase 3 Trial of Vosoritide in Children with Hypochondroplasia.

PubMed lists PMID 42713641 in NEJM evidence as Journal Article, Clinical Trial, Phase III, Randomized Controlled Trial, Multicenter Study, with publication-date metadata of 2026-09-09 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Elamipretide

ClinicalTrials.gov record NCT07531251

PeptideScanner retained ClinicalTrials.gov record NCT07531251 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was elamipretide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tesamorelin

ClinicalTrials.gov record NCT03150511

PeptideScanner retained ClinicalTrials.gov record NCT03150511 at 2026-11-15T19:17:31.036Z. Its registry update date was 2026-11-09, and PeptideScanner's reviewed identity mapping was tesamorelin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Nesiritide

Nesiritide in acute decompensated heart failure: current status and future perspectives.

PubMed lists PMID 18953274 in Reviews in cardiovascular medicine as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2008 Summer (source-text precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Oxytocin

Oxytocin and autism - A precision medicine framework to unpack mechanisms and evidence.

PubMed lists PMID 42144048 in Neuroscience and biobehavioral reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-05-16 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Icatibant

Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.

PubMed lists PMID 24749847 in Clinical and experimental immunology as Clinical Trial, Phase III, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, N.I.H., Extramural, and 1 more PubMed publication type, with publication-date metadata of 2014-08 (month precision). PeptideScanner associated the retained record with the identity slug icatibant. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Bivalirudin

Bivalirudin Versus Heparin and Protamine in Adult Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis.

PubMed lists PMID 42862663 in Annals of cardiac anaesthesia as Journal Article, Systematic Review, Meta-Analysis, Comparative Study, with publication-date metadata of 2026-10-12 (day precision). PeptideScanner associated the retained record with the identity slug bivalirudin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Oxytocin

Beyond lactation: Central oxytocin in maternal mental health and disease.

PubMed lists PMID 42002246 in Neuroscience and biobehavioral reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-04-17 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Thymosin alpha-1

ClinicalTrials.gov record NCT07922954

PeptideScanner retained ClinicalTrials.gov record NCT07922954 at 2026-11-15T22:10:40.222Z. Its registry update date was 2026-11-06, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07921316

PeptideScanner retained ClinicalTrials.gov record NCT07921316 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-06, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Leuprolide

Leuprolide acetate, a GnRH agonist, preserves cerebellar integrity and motor coordination in a rat model of hepatic encephalopathy.

PubMed lists PMID 42962871 in Physiology & behavior as Journal Article, with publication-date metadata of 2026-10-30 (day precision). PeptideScanner associated the retained record with the identity slug leuprolide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vosoritide

Vosoritide therapy in Brazil: Consensus on the Diagnosis, Monitoring, and Management of Achondroplasia.

PubMed lists PMID 42983735 in Orphanet journal of rare diseases as Journal Article, Consensus Statement, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-08-06 (day precision). PeptideScanner associated the retained record with the identity slug vosoritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Thymosin beta-4

ClinicalTrials.gov record NCT05555589

PeptideScanner retained ClinicalTrials.gov record NCT05555589 at 2026-11-16T01:44:56.605Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was thymosin-beta-4.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT07794579

PeptideScanner retained ClinicalTrials.gov record NCT07794579 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Mecasermin

Mecasermin for the treatment of Rett Syndrome: a systematic review.

PubMed lists PMID 41174329 in Neurogenetics as Journal Article, Systematic Review, with publication-date metadata of 2025-11-01 (day precision). PeptideScanner associated the retained record with the identity slug mecasermin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Oxytocin

Oxytocin, sex hormones and brain activity in facial expression processing: A sex-based systematic review.

PubMed lists PMID 41707759 in Neuroscience and biobehavioral reviews as Journal Article, Systematic Review, with publication-date metadata of 2026-02-16 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Oxytocin

Rewiring connection: The role of oxytocin in interactive media behavior.

PubMed lists PMID 41796877 in Neuroscience and biobehavioral reviews as Journal Article, Review, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Oxytocin

Reframing oxytocin as a behavioral flexibility hormone.

PubMed lists PMID 41796879 in Neuroscience and biobehavioral reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-03-06 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Oxytocin

Role of Oxytocin in Obesity.

PubMed lists PMID 42766066 in Current diabetes reports as Journal Article, Review, with publication-date metadata of 2026-09-21 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Palopegteriparatide

ClinicalTrials.gov record NCT07081997

PeptideScanner retained ClinicalTrials.gov record NCT07081997 at 2026-11-15T21:57:58.320Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was palopegteriparatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Vasopressin

Oxytocin, vasopressin, and their crosstalk in sexually-dimorphic psychiatric conditions.

PubMed lists PMID 41862144 in Neuroscience and biobehavioral reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-03-18 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Dulaglutide

ClinicalTrials.gov record NCT07668336

PeptideScanner retained ClinicalTrials.gov record NCT07668336 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was dulaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Petrelintide

ClinicalTrials.gov record NCT07843485

PeptideScanner retained ClinicalTrials.gov record NCT07843485 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was petrelintide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Petrelintide

ClinicalTrials.gov record NCT07843498

PeptideScanner retained ClinicalTrials.gov record NCT07843498 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-05, and PeptideScanner's reviewed identity mapping was petrelintide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Octreotide

Case Report: Neurosurgery, octreotide, cabergoline, radiotherapy, pasireotide and pegvisomant - a multimodal strategy for adolescent acrogigantism.

PubMed lists PMID 42978565 in Frontiers in endocrinology as Case Reports, Journal Article, with publication-date metadata of 2026-10-20 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT06672549

PeptideScanner retained ClinicalTrials.gov record NCT06672549 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT06672939

PeptideScanner retained ClinicalTrials.gov record NCT06672939 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT07202884

PeptideScanner retained ClinicalTrials.gov record NCT07202884 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT07223593

PeptideScanner retained ClinicalTrials.gov record NCT07223593 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Orforglipron

ClinicalTrials.gov record NCT07241390

PeptideScanner retained ClinicalTrials.gov record NCT07241390 at 2026-11-16T17:28:37.737Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was orforglipron.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Eloralintide

ClinicalTrials.gov record NCT07282600

PeptideScanner retained ClinicalTrials.gov record NCT07282600 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Eloralintide

ClinicalTrials.gov record NCT07353931

PeptideScanner retained ClinicalTrials.gov record NCT07353931 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Eloralintide

ClinicalTrials.gov record NCT07369011

PeptideScanner retained ClinicalTrials.gov record NCT07369011 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Eloralintide

ClinicalTrials.gov record NCT07392190

PeptideScanner retained ClinicalTrials.gov record NCT07392190 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was eloralintide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Bivalirudin

ClinicalTrials.gov record NCT03537586

PeptideScanner retained ClinicalTrials.gov record NCT03537586 at 2026-11-15T21:58:19.888Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was bivalirudin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Terlipressin

The use of terlipressin to treat refractory hypotension during allograft kidney transplantation: a report of 4 cases and literature review.

PubMed lists PMID 41204083 in BMC anesthesiology as Journal Article, Case Reports, Review, with publication-date metadata of 2025-11-07 (day precision). PeptideScanner associated the retained record with the identity slug terlipressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06857942

PeptideScanner retained ClinicalTrials.gov record NCT06857942 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06937086

PeptideScanner retained ClinicalTrials.gov record NCT06937086 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT06937099

PeptideScanner retained ClinicalTrials.gov record NCT06937099 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07697391

PeptideScanner retained ClinicalTrials.gov record NCT07697391 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07817875

PeptideScanner retained ClinicalTrials.gov record NCT07817875 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07881458

PeptideScanner retained ClinicalTrials.gov record NCT07881458 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-04, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Glucagon

Interlaboratory Comparison of a Glucagon and Oxyntomodulin Immuno-LC-MS/MS Assay: Implications for Diabetes Research.

PubMed lists PMID 42400596 in Clinical chemistry as Journal Article, Comparative Study, with publication-date metadata of 2026-11-04 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Eloralintide

ClinicalTrials.gov record NCT07900633

PeptideScanner retained ClinicalTrials.gov record NCT07900633 at 2026-11-16T01:48:01.052Z. Its registry update date was 2026-11-03, and PeptideScanner's reviewed identity mapping was eloralintide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Oxytocin

Oxytocin in chronic pain: From analgesic to biopsychosocial adjuvant - An opinion paper.

PubMed lists PMID 41619996 in Neuroscience and biobehavioral reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-01-29 (day precision). PeptideScanner associated the retained record with the identity slug oxytocin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pegcetacoplan

Mixed Intravascular and Extravascular Hemolysis Despite Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: A Case of Switching to Pegcetacoplan.

PubMed lists PMID 42972953 in Turkish journal of haematology : official journal of Turkish Society of Haematology as Journal Article, with publication-date metadata of 2026-11-03 (day precision). PeptideScanner associated the retained record with the identity slug pegcetacoplan. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Eptifibatide

Thrombolysis Alone vs With Argatroban or Eptifibatide: A Prespecified Subgroup Analysis of the MOST Trial.

PubMed lists PMID 41071964 in Neurology as Journal Article, Randomized Controlled Trial, Clinical Trial, Phase III, Multicenter Study, Comparative Study, with publication-date metadata of 2025-10-10 (day precision). PeptideScanner associated the retained record with the identity slug eptifibatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07881432

PeptideScanner retained ClinicalTrials.gov record NCT07881432 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-03, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Liraglutide

ClinicalTrials.gov record NCT07913685

PeptideScanner retained ClinicalTrials.gov record NCT07913685 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-03, and PeptideScanner's reviewed identity mapping was liraglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Retatrutide

Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain.

PubMed lists PMID 42853576 in JAMA as Journal Article, with publication-date metadata of 2026-11-03 (day precision). PeptideScanner associated the retained record with the identity slug retatrutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

Recommendations for the use of semaglutide for the management of obesity in children and young people in England: expert consensus statements using a Delphi-like process.

PubMed lists PMID 42977490 in Archives of disease in childhood as Journal Article, with publication-date metadata of 2026-11-03 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

Management of patients with cardiovascular disease and overweight/obesity: expert opinion on semaglutide use.

PubMed lists PMID 42469146 in Nutrition, metabolism, and cardiovascular diseases : NMCD as Journal Article, Review, Consensus Statement, with publication-date metadata of 2026-07-16 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Carfilzomib

ClinicalTrials.gov record NCT05497804

PeptideScanner retained ClinicalTrials.gov record NCT05497804 at 2026-11-16T17:39:29.005Z. Its registry update date was 2026-11-02, and PeptideScanner's reviewed identity mapping was carfilzomib.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Lutetium Lu 177 dotatate

ClinicalTrials.gov record NCT07910760

PeptideScanner retained ClinicalTrials.gov record NCT07910760 at 2026-11-16T01:36:36.861Z. Its registry update date was 2026-11-02, and PeptideScanner's reviewed identity mapping was lutetium-lu-177-dotatate.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT04916470

PeptideScanner retained ClinicalTrials.gov record NCT04916470 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07846865

PeptideScanner retained ClinicalTrials.gov record NCT07846865 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-02, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Tirzepatide

ClinicalTrials.gov record NCT07906041

PeptideScanner retained ClinicalTrials.gov record NCT07906041 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-02, and PeptideScanner's reviewed identity mapping was tirzepatide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Maridebart cafraglutide

ClinicalTrials.gov record NCT07908316

PeptideScanner retained ClinicalTrials.gov record NCT07908316 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-02, and PeptideScanner's reviewed identity mapping was maridebart-cafraglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07909889

PeptideScanner retained ClinicalTrials.gov record NCT07909889 at 2026-11-14T22:56:28.992Z. Its registry update date was 2026-11-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Clinical trials · Semaglutide

ClinicalTrials.gov record NCT07911046

PeptideScanner retained ClinicalTrials.gov record NCT07911046 at 2026-11-14T22:51:22.481Z. Its registry update date was 2026-11-02, and PeptideScanner's reviewed identity mapping was semaglutide.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Glucagon

Glucagon receptor agonist aggravates a murine model of Balkan nephropathy.

PubMed lists PMID 42789963 in American journal of physiology. Renal physiology as Journal Article, Research Support, N.I.H., Extramural, with publication-date metadata of 2026-09-18 (day precision). PeptideScanner associated the retained record with the identity slug glucagon. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Tirzepatide

PET Imaging of Dual GLP-1R and GIPR Targeting with [18F]AlF-NOTA-Asp2-Tirzepatide.

PubMed lists PMID 42969740 in Molecular pharmaceutics as Journal Article, with publication-date metadata of 2026-11-02 (day precision). PeptideScanner associated the retained record with the identity slug tirzepatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · GHRP-6

GHRP-6 in heifer and cow adenohypophisial cells separated by elutriation.

PubMed lists PMID 10494658 in Journal of physiology and biochemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1999-03 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Secretin

Secretin: a hormone for HCO3- homeostasis.

PubMed lists PMID 38221598 in Pflugers Archiv : European journal of physiology as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-01-15 (day precision). PeptideScanner associated the retained record with the identity slug secretin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Lutetium Lu 177 dotatate

Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis.

PubMed lists PMID 38451361 in Journal of neuro-oncology as Journal Article, with publication-date metadata of 2024-03-07 (day precision). PeptideScanner associated the retained record with the identity slug lutetium-lu-177-dotatate. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Vasopressin

International expert consensus statement on the diagnosis and management of congenital nephrogenic diabetes insipidus (arginine vasopressin resistance).

PubMed lists PMID 39438674 in Nature reviews. Nephrology as Journal Article, Review, Consensus Statement, with publication-date metadata of 2024-10-22 (day precision). PeptideScanner associated the retained record with the identity slug vasopressin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Octreotide

Cascaded deep learning for synthesis of 18F-FDG PET from 18F-octreotide: model parameter optimization and performance evaluation.

PubMed lists PMID 42964248 in Frontiers in nuclear medicine as Journal Article, with publication-date metadata of 2026-10-16 (day precision). PeptideScanner associated the retained record with the identity slug octreotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Semaglutide

Influence of Social Media on Self-Medication Behavior: A Study on Ozempic Use Among Emirati University Students.

PubMed lists PMID 42196730 in International journal of environmental research and public health as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2026-05-12 (day precision). PeptideScanner associated the retained record with the identity slug semaglutide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

October 2026

11 records on this page

Literature metadata · Rusfertide

Rusfertide for the treatment of polycythemia vera.

PubMed lists PMID 42958870 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2026-10-31 (day precision). PeptideScanner associated the retained record with the identity slug rusfertide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Etelcalcetide

Long-term use of etelcalcetide for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis for end-stage renal failure: a real-life retrospective observational study.

PubMed lists PMID 36790677 in International urology and nephrology as Observational Study, Journal Article, with publication-date metadata of 2023-02-15 (day precision). PeptideScanner associated the retained record with the identity slug etelcalcetide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

Antifungal properties of cathelicidin LL-37: current knowledge and future research directions.

PubMed lists PMID 38057654 in World journal of microbiology & biotechnology as Journal Article, Review, with publication-date metadata of 2023-12-07 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Pasireotide

Pasireotide-LAR and pegvisomant combination in resistant acromegaly: a case series of predominantly mammosomatotroph adenomas.

PubMed lists PMID 42778805 in Pituitary as Journal Article, with publication-date metadata of 2026-09-23 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Desmopressin

ClinicalTrials.gov record NCT06020495

PeptideScanner retained ClinicalTrials.gov record NCT06020495 at 2026-11-16T01:33:21.554Z. Its registry update date was 2026-10-30, and PeptideScanner's reviewed identity mapping was desmopressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Thymosin beta-4

The preliminary study of exosomes derived from thymosin beta 4-treated adipose-derived stem cells in fat grafting.

PubMed lists PMID 36445571 in Genes & genomics as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2022-11-29 (day precision). PeptideScanner associated the retained record with the identity slug thymosin-beta-4. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · Humanin

Mitochondrial-derived peptides and cytoprotection in acute respiratory distress syndrome: emerging therapeutic promise of humanin.

PubMed lists PMID 42262906 in American journal of respiratory cell and molecular biology as Editorial, Comment, with publication-date metadata of 2026-11-01 (day precision). PeptideScanner associated the retained record with the identity slug humanin. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Clinical trials · Vasopressin

ClinicalTrials.gov record NCT05958342

PeptideScanner retained ClinicalTrials.gov record NCT05958342 at 2026-11-15T22:08:31.832Z. Its registry update date was 2026-10-30, and PeptideScanner's reviewed identity mapping was vasopressin.

Source: ClinicalTrials.gov ↗

→

Literature metadata · Pasireotide

Pituitary acting drugs: cabergoline and pasireotide.

PubMed lists PMID 35670988 in Pituitary as Journal Article, Review, with publication-date metadata of 2022-06-07 (day precision). PeptideScanner associated the retained record with the identity slug pasireotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→

Literature metadata · LL-37

Antibiofilm properties of cathelicidin LL-37: an in-depth review.

PubMed lists PMID 36781570 in World journal of microbiology & biotechnology as Review, Journal Article, with publication-date metadata of 2023-02-14 (day precision). PeptideScanner associated the retained record with the identity slug ll-37. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

Source: PubMed ↗

→